AMLX
Amylyx Pharmaceuticals Inc
27.20$
-0.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | – | 100.0% | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | – | – | – | – | – | – | – | |
| 1,432.3% | – | – | 4,509.8% | – | – | – | 49.9% | 12.9% | 7.4% | 5.7% | 5.1% | 8.6% | 131.3% | – | 194.5% | – | – | – | – | – | – | – | – | |
| -1,332.3% | – | – | -4,409.8% | – | – | – | 50.1% | 87.1% | 92.6% | 94.3% | 94.9% | 91.4% | -31.3% | – | -94.5% | – | – | – | – | – | – | – | – | |
| 1,432.3% | – | – | 4,509.8% | – | – | – | 7,221.4% | 104.2% | 33.9% | 29.6% | 29.2% | 41.4% | 41.3% | – | 5,105.0% | – | – | – | – | – | – | – | – | |
| 1,122.6% | – | – | 3,631.6% | – | – | – | 8,678.3% | 257.5% | 61.6% | 44.2% | 47.4% | 39.4% | 65.2% | – | 4,285.6% | – | – | – | – | – | – | – | – | |
| 2,454.9% | – | – | 8,041.4% | – | – | – | 15,899.7% | 290.9% | 95.5% | 73.8% | 76.7% | 89.6% | 106.5% | – | 18,093.3% | – | – | – | – | – | – | – | – | |
| -2,454.9% | – | – | -8,041.4% | – | – | – | -15,849.6% | -203.8% | -2.9% | 20.6% | 18.2% | 1.8% | -137.8% | – | -18,187.7% | – | – | – | – | – | – | – | – | |
| 0.3% | – | – | 1.1% | – | – | – | 174.2% | 14.4% | 4.8% | – | – | 3.2% | – | – | – | – | – | – | – | – | – | – | – | |
| -2,454.9% | – | – | -8,120.0% | – | – | – | -15,617.7% | -192.5% | 2.0% | 24.4% | 21.8% | 6.0% | -133.7% | – | -17,476.9% | – | – | – | – | – | – | – | – | |
| 0.6% | – | – | 77.5% | – | – | – | -36.2% | 2.6% | -0.2% | 2.0% | 1.5% | 1.6% | 0.3% | – | -17,476.9% | – | – | – | – | – | – | – | – | |
| -2,454.9% | – | – | -8,120.0% | – | – | – | -15,581.4% | -195.1% | 2.2% | 22.5% | 20.3% | 4.4% | -134.0% | – | -17,476.9% | – | – | – | – | – | – | – | – | |
| -2,454.3% | – | – | -8,116.5% | – | – | – | -15,569.9% | -191.7% | 2.2% | 24.7% | 22.1% | 6.2% | -133.4% | – | -17,423.8% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.